
Exciting news to report: Pittsburgh is the U.S. site for a clinical trial with a gene-independent, cone sparing therapy for retinitis pigmentosa. SparingVision, a French company developing therapies for ocular […]
Exciting news to report: Pittsburgh is the U.S. site for a clinical trial with a gene-independent, cone sparing therapy for retinitis pigmentosa. SparingVision, a French company developing therapies for ocular […]
You know how people say, “You had to be there?” That is the case with The Eye & Ear Foundation’s November 19 webinar, “Imaging for Retinal Diseases.” It is one […]